There are a number of considerations that can help streamline the pathway to the clinic. One of the first is which vector system will be used, with AAV and lentivirus being two of the most commonly ...

Gene therapy offers the possibility of addressing cancer at its molecular roots by targeting disease-causing genes rather than relying solely on surgery, chemotherapy, or radiotherapy. Among RNA-based ...

Find out how different vaccines for the coronavirus cause your body to create antibodies that fight the virus.

Philadelphia, the birthplace of American democracy, is also the birthplace of the first FDA-approved cell and gene therapies. Now the city is home to a new company that manufactures a component key to ...

Vishal Mukund Sonje, Vaccine Manufacturing Lead, CEPI, talks about the challenges that arise in the manufacturing of vaccines ...

Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

To solve a problem, scientists first need to see it clearly. Whether it’s a virus slipping past the immune system or plaques forming in the brain, visualization is the first step toward finding ...

Ottawa, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The global viral vector gene therapy market size was valued at USD 13.14 billion in 2024 and is predicted to hit around USD 38.39 billion by 2034, rising at a ...